Article Versions Notes

Ishfaq M, Bashir N, Riaz SK, Manzoor S, Khan JS, Bibi Y, Sami R, Aljahani AH, Alharthy SA, Shahid R. Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients. Genes. 2022; 13(3):549. https://doi.org/10.3390/genes13030549

Ishfaq, Mehreen, Nabiha Bashir, Syeda Kiran Riaz, Shumaila Manzoor, Jahangir Sarwar Khan, Yamin Bibi, Rokayya Sami, Amani H. Aljahani, Saif A. Alharthy, and Ramla Shahid. 2022. "Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients" Genes 13, no. 3: 549. https://doi.org/10.3390/genes13030549

Ishfaq, M., Bashir, N., Riaz, S. K., Manzoor, S., Khan, J. S., Bibi, Y., Sami, R., Aljahani, A. H., Alharthy, S. A., & Shahid, R. (2022). Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients. Genes, 13(3), 549. https://doi.org/10.3390/genes13030549